FIELD: organic chemistry, medicine, pharmacy.
SUBSTANCE: invention relates to compounds of the formula (I) , methods for their synthesis and their using for therapeutic treatment of the nervous system disorders associated with 5-HT-6 receptor. Invention provides synthesis of novel biologically active substances of the formula (I) and pharmaceutical compositions based on thereof used in treatment of the nervous system disorders and controlled by 5-HT-6 receptors.
EFFECT: valuable medicinal properties of compounds and pharmaceutical compositions.
6 tbl, 82 ex
Title | Year | Author | Number |
---|---|---|---|
INDOLYLALKYLAMINE DERIVATIVES AS 5-HYDROHYTRIPTAMINE-6 LIGANDS | 2002 |
|
RU2309157C2 |
INDOLES AS 5-HT MODULATORS | 2007 |
|
RU2449990C2 |
PYRROLOCHINOLINE DERIVATIVES AS 5-HT ANTAGONISTS, METHODS FOR PRODUCTION THEREOF AND USE | 2013 |
|
RU2688161C2 |
HETEROCYCLYL-3-SULFONYLINDAZOLES AS 5-HYROXYTRYPTAMINE-6 LIGANDS | 2004 |
|
RU2347780C2 |
CATECHOL-O-METHYL TRANSFERASE INHIBITORS AND USE THEREOF IN TREATING PSYCHOTIC DISORDERS | 2011 |
|
RU2586974C2 |
PYRROLOPYRIDINES EFFECTIVE AS PROTEINKINASE INHIBITORS | 2006 |
|
RU2435769C2 |
BROMDOMAIN INHIBITORS | 2012 |
|
RU2671571C1 |
BICYCLIC HETEROCYCLIC COMPOUNDS AS ANTI-INFLAMMATORY AGENTS | 2006 |
|
RU2426733C2 |
QUINOLINE COMPOUNDS SUITABLE FOR TREATING DISORDERS RESPONDING TO MODULATION OF SEROTONIN 5-HT RECEPTOR | 2008 |
|
RU2483068C2 |
NEW COMPOUNDS AND COMPOSITIONS FOR NAMPT INHIBITION | 2011 |
|
RU2617988C2 |
Authors
Dates
2008-01-20—Published
2003-06-03—Filed